VANCOUVER, British Columbia / TheNewswire / April 10, 2017: Wildflower Marijuana Inc. (CSE: SUN) (FWB: RSP) (“Wildflower” or the "Company") signs a wholesale brokerage agreement with one of the world’s largest retail brokers, making Wildflower the first cannabis company to transition from the specialized cannabis market to mainstream retail distribution.

Wildflower’s full line of hemp derived CBD+ products including CBD based topical, soaps, capsules and vaporizers will be distributed throughout the United States where CBD is legal in all 50 States.

With 165 offices in the United States and Canada and employing 40,000 people, the wholesale broker provides Wildflower a large sales force to market and build out the retail distribution for its CBD+ products.  As sales terms and conditions are set by Wildflower, including timing and pricing, and negotiated by the wholesaler with the retailer, it allows Wildflower to do a staged roll-out with an initial focus on health and wellness retailers to allow Wildflower to ramp up production and prepare for the larger national retailers.  

Wildflower is coordinating orders with its production capabilities.  Production facilities are being expanded and streamlined in order to meet the expected demand.  As the first cannabis company to make the transition from specialized medical and cannabis markets to mainstream retail distribution, Wildflower is preparing specialized marketing and educational tools for the sales force.

Wildflower CEO, William MacLean stated, “Accessing the retail consumer goods market is a great milestone for our company.  With such a unique blend of products we were able to offer products that could go into multiple retail categories such as conventional retail, natural whole products, pharmacies and specialty health stores.  With the government of Canada in the process of legalizing cannabis the timing couldn’t be better for us to secure access into the North American retail market.”  

 

About Wildflower Marijuana Inc.

Wildflower is a cannabis company focused on developing and designing branded cannabis products.  Wildflower sells its CBD+ products online and to retailers throughout the US and also produces and markets its THC products in regulated cannabis jurisdictions.

On Behalf of the Board of Directors

 

“William MacLean”

____________________________________

William MacLean

Director and CEO

THIS NEWS RELEASE, PROVIDED PURSUANT TO APPLICABLE CANADIAN REQUIREMENTS, IS NOT FOR DISTRIBUTION TO U.S. NEWS SERVICES OR FOR DISSEMINATION IN THE UNITED STATES, AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN. THESE SECURITIES HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS, AND MAY NOT BE OFFERED OR SOLD IN THE UNITED STATES OR TO U.S. PERSONS ABSENT REGISTRATION OR APPLICABLE EXEMPTION FROM REGISTRATION REQUIREMENTS.

Cautionary and Forward-Looking Statements

This news release contains forward‐looking statements and forward‐looking information within the meaning of applicable securities laws. These statements relate to future events or future performance. All statements other than statements of historical fact may be forward‐looking statements or information. Forward‐looking statements and information are often, but not always, identified by the use of words such as "appear", "seek", "anticipate", "plan", "continue", "estimate", "approximate", "expect", "may", "will", "project", "predict", "potential", "targeting", "intend", "could", "might", "should", "believe", "would" and similar expressions.

Forward-looking statements and information are provided for the purpose of providing information about the current expectations and plans of management of the Company relating to the future. Readers are cautioned that reliance on such statements and information may not be appropriate for other purposes, such as making investment decisions. Since forward‐looking statements and information address future events and conditions, by their very nature they involve inherent risks and uncertainties. Actual results could differ materially from those currently anticipated due to a number of factors and risks. These include, but are not limited to, the risks associated with the marijuana industry in general such as operational risks in growing; competition; incorrect assessment of the value and potential benefits of various transactions; ability to access sufficient capital from internal and external sources; failure to obtain required regulatory and other approvals and changes in legislation, including but not limited to tax laws and government regulations. Accordingly, readers should not place undue reliance on the forward‐looking statements, timelines and information contained in this news release. Readers are cautioned that the foregoing list of factors is not exhaustive.

The forward‐looking statements and information contained in this news release are made as of the date hereof and no undertaking is given to update publicly or revise any forward‐looking statements or information, whether as a result of new information, future events or otherwise, unless so required by applicable securities laws or the Canadian Securities Exchange. The forward-looking statements or information contained in this news release are expressly qualified by this cautionary statement.

The Canadian Securities Exchange Inc. has in no way passed upon the merits of the proposed transaction and has neither approved nor disapproved of the contents of this press release.